top of page

Elica Equity Fund is an investment Fund focused on listed equities of emerging biotech companies
worldwide that are developing novel drugs for unmet clinical needs.

 

Elica Equity Fund is a sub-Fund of the Liechtenstein registered Riverfield Alpine Fund (FCP)​. Riverfield Alpine Fund is a UCITS pursuant to Liechtenstein law with the legal form of a contractual investment fund (FCP).

 

​For additional information please contact np@riverfieldpartners.co.uk or visit the IFM (Management Company) website

Riverfield Partners LLP is authorised and regulated by the Financial Conduct Authority (FCA)

Riverfield Partners LLP Succursale Italiana (CF/P.IVA 10313820960, Numero REA MI - 2521807). Reclami - Sostenibilità - Whistleblowing​

bottom of page